Altimmune Inc to Host Key Opinion Leader Call on Pemvidutide Phase 1 Clinical Trial Results - Conference Call Transcript - Thomson StreetEvents

Altimmune Inc to Host Key Opinion Leader Call on Pemvidutide Phase 1 Clinical Trial Results - Conference Call Transcript

Altimmune Inc to Host Key Opinion Leader Call on Pemvidutide Phase 1 Clinical Trial Results - Conference Call Transcript - Thomson StreetEvents
Altimmune Inc to Host Key Opinion Leader Call on Pemvidutide Phase 1 Clinical Trial Results - Conference Call Transcript
Published Sep 30, 2021
14 pages (10244 words) — Published Sep 30, 2021
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of ALT.OQ conference call or presentation 30-Sep-21 1:00pm GMT

  
Brief Excerpt:

...Operator Greetings, and welcome to the Altimmune, Inc. Key Opinion Leader call on pemvidutide under development for obesity and NASH. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Mr. Will Brown, Chief Financial Officer. Thank you. You may begin. William Michael Brown ...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Altimmune Inc
Ticker
ALT.OQ
Time
1:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Altimmune Inc at JMP Securities Life Sciences Conference Transcript – 2022-06-16 – US$ 54.00 – Edited Transcript of ALT.OQ presentation 16-Jun-22 1:00pm GMT

Altimmune Inc Q1 2022 Earnings Call Transcript – 2022-05-12 – US$ 54.00 – Edited Transcript of ALT.OQ earnings conference call or presentation 12-May-22 12:30pm GMT

Altimmune Inc Q4 2021 Earnings Call Transcript – 2022-03-15 – US$ 54.00 – Edited Transcript of ALT.OQ earnings conference call or presentation 15-Mar-22 12:30pm GMT

Altimmune Inc Q3 2021 Earnings Call Transcript – 2021-11-10 – US$ 54.00 – Edited Transcript of ALT.OQ earnings conference call or presentation 10-Nov-21 1:30pm GMT

Altimmune Inc at H C Wainwright NASH Investor Conference (Virtual) Transcript – 2021-10-12 – US$ 54.00 – Edited Transcript of ALT.OQ presentation 12-Oct-21 7:30pm GMT

Altimmune Inc to Discuss the 12-Week Data from Phase 1 Clinical Trial of ALT-801 - Conference Call Transcript – 2021-09-28 – US$ 54.00 – Edited Transcript of ALT.OQ conference call or presentation 28-Sep-21 12:30pm GMT

Altimmune Inc Q2 2021 Earnings Call Transcript – 2021-08-11 – US$ 54.00 – Edited Transcript of ALT.OQ earnings conference call or presentation 11-Aug-21 12:30pm GMT

Altimmune Inc Positive Interim Data From ALT-801 Phase 1 Trial In Overweight And Obese Volunteers Conference Call Transcript – 2021-06-16 – US$ 54.00 – Edited Transcript of ALT.OQ conference call or presentation 16-Jun-21 12:30pm GMT

Altimmune Inc Q1 2021 Earnings Call Transcript – 2021-05-17 – US$ 54.00 – Edited Transcript of ALT.OQ earnings conference call or presentation 17-May-21 12:30pm GMT

Altimmune Inc to Present AdCOVIDâ„¢ intranasal COVID-19 at the World Vaccine Congress Transcript – 2021-05-04 – US$ 54.00 – Edited Transcript of ALT.OQ corporate analyst meeting</ 4-May-21 10:59am GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Altimmune Inc to Host Key Opinion Leader Call on Pemvidutide Phase 1 Clinical Trial Results - Conference Call Transcript" Sep 30, 2021. Alacra Store. May 04, 2024. <http://www.alacrastore.com/thomson-streetevents-transcripts/Altimmune-Inc-to-Host-Key-Opinion-Leader-Call-on-Pemvidutide-Phase-1-Clinical-Trial-Results-Conference-Call-T14997389>
  
APA:
Thomson StreetEvents. (2021). Altimmune Inc to Host Key Opinion Leader Call on Pemvidutide Phase 1 Clinical Trial Results - Conference Call Transcript Sep 30, 2021. New York, NY: Alacra Store. Retrieved May 04, 2024 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Altimmune-Inc-to-Host-Key-Opinion-Leader-Call-on-Pemvidutide-Phase-1-Clinical-Trial-Results-Conference-Call-T14997389>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.